TactioRPM Touts FDA Registration

TactioRPM Touts FDA RegistrationmHealthWatch has learned that Tactio‘s remote patient monitoring platform TactioRPM is now registered at the U.S. Food and Drug Administration (FDA) as a Class 1 Medical Device Data System (MDDS).

If you’re not familiar, TactioRPM combines science-based mobile apps, web tools, HIPAA-compliant secured cloud services and vendor-agnostic connected health device integrations to allow clinicians to view patient generated data remotely, provide educational content and engage patients in a new mobile-centric, connected healthcare relationship.

TactioRPM also serves up a set of APIs for healthcare organization to build further data integration, process automation and specific applications.
“We started at Tactio from an early mobile health vision into unchartered healthcare regulatory territories. Now that mobile health has entered the daily lives of millions in several countries, the landscape is clearer for developers, payers, providers and regulators which is a very positive sign of maturity and growth for the entire industry,” said Michel Nadeau, CEO of Tactio Health Group.

“Registration of TactioRPM as a Class 1 MDDS is a natural start for the growth of our platform’s deployments in the U.S. healthcare market,” Nadeau added.

This post was written by:

- who has written 626 posts on mHealthWatch.

Contact the author